Patent details

EP1319000 Title: USE OF 1-AZABICYCLO 2.2.2 OCTAN-3-ONE DERIVATIVES FOR TREATING CANCER TUMORS

Basic Information

Publication number:
EP1319000
PCT Application Number:
PCT/SE/2001/002008
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019704212
PCT Publication Number:
WO/2002/024692
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF 1-AZABICYCLO 2.2.2 OCTAN-3-ONE DERIVATIVES FOR TREATING CANCER TUMORS
French Title of Invention:
UTILISATION DE DERIVES DE 1-AZABICYCLO(2.2.2)OCTAN-3-ONE POUR TRAITER DES TUMEURS CANCEREUSES
German Title of Invention:
VERWENDUNG VON 1-AZABICYCLO(2.2.2)OCTAN-3-ON-DERIVATEN ZUR BEHANDLUNG VON KREBSTUMOREN
SPC Number:

Dates

Filing date:
19/09/2001
Grant date:
05/11/2008
EP Publication Date:
05/11/2008
PCT Publication Date:
28/03/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/06/2003
EP B1 Publication Date:
05/11/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/09/2009
Expiration date:
19/09/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/12/2008
 
 

Name:
APREA AB
Address:
Nobels väg 3, 171 77 Stockholm, Sweden (SE)

Inventor

1

Name:
WIMAN Klas
Address:
Sweden (SE)

2

Name:
BYKOV Vladimir
Address:
Sweden (SE)

3

Name:
SELIVANOVA Galina
Address:
Sweden (SE)

Priority

Priority Number:
234164 P
Priority Date:
20/09/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/439;
Filing date Document type Number of pages